Association of time interval between cancer diagnosis and initiation of palliative chemotherapy with overall survival in patients with unresectable pancreatic cancer-Reference-Cited by-同舟云学术

Association of time interval between cancer diagnosis and initiation of palliative chemotherapy with overall survival in patients with unresectable pancreatic cancer

Published:2019-05-17 Issue:7 Volume:8 Page:3471-3478
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Lee Shu‐Hui¹,Chang Pei‐Hung²,Chen Ping‐Tsung³,Lu Chang‐Hsien³,Hung Yu‐Shin⁴,Tsang Ngan‐Ming⁵^ORCID,Hung Chia‐Yen⁴⁶^ORCID,Chen Jen‐Shi⁴,Hsu Hung‐Chih⁴^ORCID,Chen Yen‐Yang⁷,Chou Wen‐Chi⁴^ORCID

Affiliation:

1. Department of Nursing, College of Medicine Chang Gung Memorial Hospital at Linkou and Chang Gung University Taoyuan Taiwan

2. Department of Hematology‐Oncology Chang Gung Memorial Hospital at Keelung Keelung Taiwan

3. Department of Hematology‐Oncology Chang Gung Memorial Hospital Chiayi Taiwan

4. Department of Hematology‐Oncology, College of Medicine Chang Gung Memorial Hospital at Linkou and Chang Gung University Taoyuan Taiwan

5. Department of Radiation Oncology, College of Medicine Chang Gung Memorial Hospital at Linkou and Chang Gung University Taoyuan Taiwan

6. Department of Hematology‐Oncology Mackay General Hospital Taipei Taiwan

7. Department of Hematology‐Oncology Chang Gung Memorial Hospital at Kaohsiung Kaohsiung Taiwan

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2254

Reference26 articles.

1. Cancer statistics, 2018

2. Incidence and mortality of pancreatic cancer on a rapid rise in Taiwan, 1999–2012

3. Pancreatic cancer epidemiology, detection, and management;Zhang Q;Gastroenterol Res Pract,2016

4. Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer

5. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of a patient-specific avatar organoid model derived from EUS-guided fine-needle biopsy for timely clinical application in pancreatic ductal adenocarcinoma (with video);Gastrointestinal Endoscopy;2024-07

2. Impact of time from diagnosis to chemotherapy on prognosis in advanced pancreatic cancer;Japanese Journal of Clinical Oncology;2024-02-29

3. Impact of time from diagnosis to chemotherapy on prognosis in advanced pancreatic cancer;2023-12-04

4. An analysis of time to treatment in patients with pancreatic adenocarcinoma;Surgery;2023-07

5. Individualized number of induction chemotherapy cycles for locoregionally advanced nasopharyngeal carcinoma patients based on early tumor response;Cancer Medicine;2022-09-20